| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |